All AbMole products are for research use only, cannot be used for human consumption.
For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.
Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP) antibody, with potential anti-amyloid activity. Dezamizumab triggers immunotherapeutic clearance of amyloid. Dezamizumab can be used in research of Amyloid light-chain (AL) amyloidosis.
CAS Number | 1662664-56-3 |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
[5] Mark B Pepys. Front Immunol. The Pentraxins 1975-2018: Serendipity, Diagnostics and Drυgs
Related Products |
---|
DC-Y13-27
DC-Y13-27, a derivative of DC-Y13, is a YTHDF2 inhibitor (KD = 37.9 μM). DC-Y13-27 enhances tumor responses to radiotherapy and immunotherapy. |
GAK inhibitor 49
GAK inhibitor 49 is a potent, ATP-competitive and highly selective cyclin G associated kinase (GAK) inhibitor with a Ki of 0.54 nM and a cell IC50 of 56 nM. |
Corticotropin Releasing Factor
CRF is a hypothalamic peptide that releases ACTH and endorphin from the anterior pituitary. It is also a neurotransmitter in the central nervous system, and is involved in autonomic and endocrine responses to stress. |
Isoxanthopterin
Isoxanthopterin is a heterocyclic compound belonging to the pteridine family. |
EGTA-AM
EGTA-AM is a membrane permeable form of EGTA, which can be passively loaded into cells to generate intracellular EGTA. EGTA-AM is also a Ca2+ chelator with slow chelating dynamics. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.